| SIGNS & SYMPTOMS |
|
- jaundice
- fatigue
- abdominal pain
- loss of appetite
|
- nausea, vomiting
- joint pain
- dark (tea colored) urine
|
| CAUSE |
|
LONG-TERM EFFECTS
WITHOUT VACCINATION |
- HDV can be acquired either as
- a co-infection (occurs simultaneously) with hepatitis B virus (HBV) or
- as a superinfection in persons with existing chronic HBV infection.
- HBV-HDV co-infection:
- may have more severe acute disease and a higher risk (2%-20%) of developing acute liver failure compared with those infected with HBV alone
- HBV-HDV superinfection
- chronic HBV carriers who acquire HDV superinfection usually develop chronic HDV infection
- progression to cirrhosis is believed to be more common with HBV/HDV chronic infections
|
| TRANSMISSION |
- Occurs when blood from an infected person enters the body of a person who is not immune.
- HBV is spread through having sex with an infected person without using a condom (the efficacy of latex condoms in preventing infection with HBV is unknown, but their proper use may reduce transmission);
- By sharing drugs, needles, or "works" when "shooting" drugs;
- Through needlesticks or sharps exposures on the job; or
- From an infected mother to her baby during birth.
|
| RISK GROUPS |
- Injection drug users
- Men who have sex with men
- Haemodialysis patients
- Sex contacts of infected persons
|
- Health care and public safety workers
- Infants born to infected mothers
(very rare)
|
| PREVENTION |
- Hepatitis B vaccination
- HBV-HDV coinfection
- pre- or post-exposure prophylaxis (hepatitis B immune globulin or vaccine) to prevent HBV infection
- HBV-HDV superinfection
- education to reduce risk behaviours among persons with chronic HBV infection
|
| VACCINE RECOMMENDATIONS |
- Hepatitis B vaccine should be given to prevent HBV/HDV co-infection
|
| TREATMENT & MEDICAL MANAGEMENT |
- Acute HDV infection
- Chronic HDV infection
- interferon-alfa
- liver transplant
|
| TRENDS & STATISTICS
|
- Routine surveillance data are not available.
|